AI NewsWaveKT and Medical AI Firm Acryl to Jointly Pursue Medical AX Projects for Healthcare Institutions
Key points
- KT and Acryl sign agreement to jointly pursue medical AX
- Cooperation from hospital data standardization to AI service validation
- Plan to identify AI models tailored to each hospital
KT will jointly pursue a medical AX (AI transformation) project with medical AI firm Acryl to help healthcare institutions use data and adopt AI services. KT announced this on Oct. 20. According to iNews24, the two companies' CEOs are KT CEO Park Yoon-young and Acryl CEO Park Oi-jin.
Digital Today reported that the two companies signed a memorandum of understanding (MOU) at Acryl's headquarters in Seolleung, Seoul. The cooperation is based on KT's integrated build-out capabilities in AI, cloud and data and its experience running medical AX projects, along with Acryl's medical data and AI technology.
Outlets described the scope of cooperation differently. IT Chosun reported that the companies will cooperate from hospital data standardization through AI service development and validation. EBN reported that they will work to identify AI models tailored to each hospital, and Techworld News described the project as spanning everything from using medical data to building AI services.
iNews24 also reported the background that the use of AI in healthcare is widening beyond clinical support into data use, research and administration.